1-6 of 6
Thomas E. Hughes
Close
Sort by
Journal Articles

Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation

Meredith J. McAdams, Mustafa Hyder, Dimana Dimitrova, Jennifer L. Sadler, Christi McKeown, Seth M. Steinberg, Amy Chai, Scott Napier, Anita Stokes, Jennifer Sponaugle, Thomas E. Hughes, Nu Ri Cha, Jennifer Cuellar-Rodriguez, Melissa Walker, Ronald E. Gress, Jennifer A. Kanakry, Christopher G. Kanakry
Journal: Blood
Blood (2021) 138 (Supplement 1): 101.
https://doi.org/10.1182/blood-2021-146997
Published: 2021
Journal Articles

Outcome of Repeated Vaccination to Hepatitis B Virus in Patients Failing to Respond to Vaccination Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): If at First You Don't Succeed, Try Try Again

Reem A Shalabi, PharmD, Michelle A Borg, PharmD, Thomas E Hughes, PharmD, Tracey Walsh-Chocolaad, PharmD, Rodica Ciurea, Lisa Cook, Tatyana Worthy, MSN, Kristen Gunn, Brian Wells, Georg Aue, Xin Tian, Richard W. Childs, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2012.
https://doi.org/10.1182/blood-2019-127336
Published: 2019
Journal Articles

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Inhye E. Ahn, Mohammed Z. H. Farooqui, Xin Tian, Janet Valdez, Clare Sun, Susan Soto, Jennifer Lotter, Stephanie Housel, Maryalice Stetler-Stevenson, Constance M. Yuan, Irina Maric, Katherine R. Calvo, Pia Nierman, Thomas E. Hughes, Nakhle S. Saba, Gerald E. Marti, Stefania Pittaluga, Sarah E. M. Herman, Carsten U. Niemann, Lone B. Pedersen, Christian H. Geisler, Richard Childs, Georg Aue, Adrian Wiestner
Journal: Blood
Blood (2018) 131 (21): 2357–2366.
https://doi.org/10.1182/blood-2017-12-820910
Published: 2018
Includes: Supplemental data
Journal Articles

Safety and Feasibility of Ultra-Low Dose IL-2 As Graft Versus Host Disease Prophylaxis in Haplo-Identical Stem Cell Transplantation- a Proof of Concept Pilot Study

Sawa Ito, MD PhD, Prachi Jain, MD, Caroline R Cantilena, BA, Prathima Anandi, MD, Kit Lu, MD, Fariba Chinian, Debbie Draper, RN, Libby Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Andra Krauze, MD, David Stroncek, MD, Adams Sharon, MT, Thomas E. Hughes, PharmD, Pawel Muranski, MD, Minoo Battiwalla, MDMS, John Barrett, MD
Journal: Blood
Blood (2016) 128 (22): 386.
https://doi.org/10.1182/blood.V128.22.386.386
Published: 2016
Journal Articles

Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial

Lauren M. Curtis, MD, Steven Z. Pavletic, MD, Rachel B. Salit, MD, Brian C Shaffer, MD, Seth M. Steinberg, PhD, Jennifer S. Wilder, RN, Filip Pirsl, Bazetta Blacklock-Schuver, RN, Jennifer Hsu, RN, Thomas E. Hughes, PharmD, David Stroncek, MD, Sharon Adams, Jennifer Hendricks, LCSW-C, Daniele N. Avila, CRNP, Jennifer Mann, CRNP, David C. Halverson, MD, Thea M. Friedman, PhD, Robert Korngold, PhD, Juan C. Gea-Banacloche, MD, Daniel H. Fowler, MD, Dennis L. Confer, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2015) 126 (23): 65.
https://doi.org/10.1182/blood.V126.23.65.65
Published: 2015
Journal Articles

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Sanaz Nicky Soltani, MD, Ramaprasad Srinivasan, MD, PhD, Theresa Jerussi, PAc, A. John Barrett, Thomas E Hughes, PharmD, BCOP, Catalina Ramos, RN, BSN, Lisa Cook, RN, BSN, Elena Cho, RN, MSN, Richard W. Childs, MD
Journal: Blood
Blood (2013) 122 (21): 4624.
https://doi.org/10.1182/blood.V122.21.4624.4624
Published: 2013